Hyloris Outlines Ambitious Growth Strategy During Full-Year Results

Belgian Value-Added Medicines Specialist Wraps Up A Successful Year In Business

 
• By Chloe Kent

Hyloris expects to expand its portfolio to around 30 candidates by 2024, bolstered by €50m in cash and cash equivalents as of the end of 2021.

Tiered wooden blocks on pink background representing growth
Hyloris' profits have grown to €3.1m during 2021 • Source: Alamy

More from Earnings

More from Business